Market Tracker

10/20 5:16pm ET

ImmunoCellular Therapeutics Ltd (NYSE American:IMUC)

0.3977
Delayed Data
As of Oct 20
 +0.0077 / +1.97%
Today’s Change
0.25
Today|||52-Week Range
4.58
-80.60%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.39
Today’s open0.39
Day’s range0.37 - 0.41
Volume2,141,039
Average volume (3 months)2,330,213
Market cap$6.3M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-31.50%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.22

Competitors

 Today’s
change
Today’s
% change
SGLBSigma Labs Inc+0.05+2.86%
YTENYield10 Bioscience I...-0.17-4.74%
BASIBioanalytical System...+0.07+3.68%
OPGNOpGen Inc-0.00-0.38%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 10, 2017
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$0.00
Annual profit (last year)-$22.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Secretary
Gary S. Titus
President, Chief Executive Officer &
Director
Anthony J. Gringeri
Corporate headquarters
Calabasas, California

Forecasts